Microbiological diagnostics of fungal infections

Corrado Girmenia

DOI: https://doi.org/10.7175/rhc.v4i1S.862

Abstract

Laboratory tests for the detection of fungal infections are easy to perform. The main obstacle to a correct diagnosis is the correlation between the laboratory findings and the clinical diagnosis. Among pediatric patients, the most common fungal pathogen is Candida. The detection of fungal colonization may be performed through the use of chromogenic culture media, which allows also the identification of Candida subspecies, from which pathogenicity depends. In neonatology, this
test often drives the decision to begin a empiric therapy; in this regard, a close cooperation between microbiologists and clinicians is highly recommended. Blood culture, if positive, is a strong confirmation of fungal infection; however, its low sensitivity results in a high percentage of false negatives, thus decreasing its reliability. Molecular diagnostics is still under evaluation, whereas the detection of some fungal antigens, such as β-D-glucan, galactomannan, mannoprotein, and cryptococcal antigen in the serum is used for adults, but still under evaluations for pediatric patients.

Keywords

Fungal infections; Diagnosis; Laboratory tests; Colonization; Blood culture; Molecular diagnostics; Fungal antigens

Full Text

HTML PDF

References

  • Manzoni P, Farina D, Leonessa M, et al. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 2006; 118: 2359-64; http://dx.doi.org/10.1542/peds.2006-1311
  • Girmenia C, Martino P, De Bernardis F, et al. Assessment of detection of Candida mannoproteinemia as a method to differentiate central venous catheter-related candidemia from invasive disease. J Clin Microbiol 1997; 35: 903-6
  • Mokaddas E, Burhamah MH, Khan ZU, et al. Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species. BMC Infect Dis 2010; 10: 292; http://dx.doi.org/10.1186/1471-2334-10-292
  • Mularoni A, Furfaro E, Faraci M, et al. High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease. Clin Vaccine Immunol 2010; 17: 882-3; http://dx.doi.org/10.1128/CVI.00038-10
  • Marchetti O, Lamoth F, Mikulska M, et al; European Conference on Infections in Leukemia (ECIL) Laboratory Working Groups. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 2012; 47: 846-54; http://dx.doi.org/10.1038/bmt.2011.178

Statistics

Abstract: 272 views
HTML: 1152 views
PDF: 326 views

Refbacks

  • There are currently no refbacks.




© SEEd srl